2-Acetylaminofluorene
A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Year introduced: 1983
PubMed search builder options
Subheadings:
Tree Number(s): D02.065.064.150, D02.241.081.018.110.080, D02.455.426.559.847.389.050, D04.615.389.050
MeSH Unique ID: D015073
Registry Number: 9M98QLJ2DL
Entry Terms:
- 2 Acetylaminofluorene
- 2-Acetamidofluorene
- 2 Acetamidofluorene
- 2-Fluorenylacetamide
- 2 Fluorenylacetamide
- Fluoren-2-ylacetamide
- Fluoren 2 ylacetamide
- 2-AAF
- N-Acetyl-2-Aminofluorene
- N Acetyl 2 Aminofluorene
- AAF, Aminofluorene
- Aminofluorene AAF
- N-2-Fluorenylacetamide
- N 2 Fluorenylacetamide
- Acetylaminofluorene
Previous Indexing:
Pharmacologic Action: